Stay updated with breaking news from Biodesix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 286,600 shares, an increase of 70.0% from the June 15th total of 168,600 shares. Based on an average trading volume of 70,700 shares, the […]
Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 286,600 shares, a growth of 70.0% from the June 15th total of 168,600 shares. Based on an average daily trading volume, of 70,700 shares, the short-interest ratio […]
Biodesix, Inc. (NASDAQ:BDSX – Get Rating) Director Jack W. Schuler acquired 52,508 shares of the business’s stock in a transaction that occurred on Thursday, May 25th. The shares were acquired at an average cost of $1.36 per share, for a total transaction of $71,410.88. Following the completion of the acquisition, the director now owns 20,563,212 […]
Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that three new scientific abstracts will be presented as part of the 2023 American... | June 1, 2023
Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host... | May 31, 2023